Monkeypox in Erie: Denise Johnson, M.D., PA secretary of health
Denise Johnson, M.D., Pennsylvania's physician general and acting secretary of health, talks about monkeypox during a visit to Erie on July 14.
David Bruce, Erie Times-News
Erie County residents at high risk of getting monkeypox, but haven't been exposed to the virus, could soon be eligible for vaccines.
The Erie County Department of Health will receive 80 more doses of JYNNEOS vaccine later this week or early next week, said Erin Mrenak, director of the county health department. It received an initial batch of 40 doses about two weeks ago.
More: Monkeypox vaccine available at Erie County Department of Health
"As our capacity increases, we will be able to expand vaccinations to other eligible groups or conduct pre-exposure vaccinations," Mrenak said. "We will follow state health department guidelines."
Vaccinations currently are limited mostly to people who have been in close contact with those diagnosed with the viral illness. Only one confirmed case of monkeypox has been found in the county.
More: Monkeypox arrives in Erie, public health threat less because spread is slower
A monkeypox outbreak has been spreading around the world since it was first detected earlier this year. The virus spreads through prolonged and close skin-to-skin contact, which can include hugging, cuddling and kissing, as well as through the sharing of bedding, towels and clothing.
People getting sick so far have mainly been men who have sex with men, though the virus can infect anyone, Mrenak said.
More: Monkeypox is spreading through sex, but it's not an STD. Why calling it one is a problem.
"Monkeypox is not an STD, though it can be spread through sexual practice," Mrenak said. "It can be spread through respiratory droplets, exposure to open sores or sharing certain objects."
More: After repeating early COVID mistakes, US now has the worlds biggest monkeypox outbreak
One problem with containing the monkeypox outbreak is a lack of free testing. Though testing is available at many local clinics and physician offices, Mrenak said free testing is not yet available.
"It's a concern because of the number of people who don't have a primary-care physician or don't have health insurance," Mrenak said. "We are working on coming up with solutions for that."
The primary symptom of monkeypox is a rash that can look like pimples or blisters that appear on the face, inside the mouth, and on other parts of the body, like the hands, feet, chest, genitals or anus,according to the Centers for Disease Control & Prevention. A person can also develop flu-like symptoms like a fever, headache and chills.
More: Addressing myths about monkeypox: A look at symptoms, treatment and other common questions
Most people who develop monkeypox recover completely within a month, local health officials have said. The mortality rate is 1% to 3%.
If you think you have been exposed to monkeypox or have the virus, contact your doctor or call the county health department at 814-451-6700.
The Associated Press contributed to this story.
Contact David Bruce atdbruce@timesnews.com. Follow him on Twitter@ETNBruce.
As monkeypox numbers continue to climb, many of us are wondering how to respond to the outbreak and be prepared in case of infection.
So, who is most at risk? People who have numerous sexual partners are most likely to become infected. As of now, the virus has mostly affected men who have sex with men, but monkeypox can spread to anyone who has direct or intimate contact with someone infected.
There are two vaccines available in the U.S. These include:
The preferred vaccine is Jynneos (imvamune, imvanex), which is live but non-replicating, so it cannot cause infection and is safe to use in immunocompromised people and during pregnancy, Dr. Geoffrey Rutledge, Chief Medical Officer and Founder of HealthTap, explains. Unfortunately, this vaccine is in short supply. Its use and eligibility for getting it are determined in each region by the local public health authority.
This is a live virus vaccine that causes a very mild infection that prevents monkeypox. It is not recommended for people who are pregnant or who have weakened immune systems. After vaccination, the person may be able to transmit the vaccine virus to others, including to pregnant women or those who have weakened immune systems, says Dr. Rutledge.
Related: What Is Monkeypox, and How Worried Should We Be? Here's What Doctors Say
To schedule an appointment for the vaccine, you can contact your local or state health department. However, distribution is limited at this time. To be eligible for the vaccine you must meet the following criteria:
People who have been identified by public health officials as a contact of someone with monkeypox
People who may have been exposed to monkeypox, which includes:
One of your sexual partners in the past two weeks has been diagnosed with monkeypox
Having numerous sexual partners in the past two weeks in a location with known monkeypox cases.
The vaccine will be effective even after exposure, so health officials advise getting vaccinated within four days of the date of exposure to reduce the risk of infection.
Story continues
"Vaccination is most important for people with a known exposure to monkeypoxvaccination within four days of exposure will prevent the disease, says Dr. Rutledge. From five days to two weeks after exposure, vaccination will reduce the severity of the illness. Vaccination is also recommended for people who are at high risk of exposure to monkeypoxpeople who have multiple sexual partners, particularly if they are in an area of the country where there are more cases, as well as healthcare workers who may come in contact with monkeypox patients or who are delivering the live attenuated vaccine (ACAM200)."
Next up: Doctors Explain These Are the First Symptoms of Monkeypox to Look Out For
Health officials around the world are racing to curb an outbreak of monkeypox cases that has swelled into the thousands, deploying both vaccines and treatments to fight a disease that can lead to weeks of painful rashes and lesions for those infected. On Aug. 4, the Biden administrationdeclared a public health emergencyto help ramp up the federal response.
Some citiesfacing outbreaks have now declared emergencies to battle the virus, as well as the states of New York, Illinoisand California.
The White House announced on Aug. 2that it's tapping two officials from the Centers for Disease Control and Prevention and the Federal Emergency Management Agency to coordinate the "whole-of-government response" to the outbreak.
While monkeypox infections have been seen before in the U.S. in two travelers from Nigeria last year and in 47 cases that were linked to imported animals back in 2003 the current outbreak is by far the largest recorded in American history and is expected to continue to grow.
Here's what's known about the monkeypox outbreak and response:
Over 7,100 cases were tallied by the Centers for Disease Control and Prevention across all but two states Montana and Wyoming as of Aug. 4.
New York is the state with the largest total number of reported cases, making up close to a quarter of the nation's overall tally.
Officials say the "vast majority" of cases in the current outbreak have spread among men who have sex with men so far, generally through skin-to-skin intimate contact or by sharing contaminated towels and bedding.
A handful of cases have also been reported in young children and pregnant women, who are believed to be at higher risk of severe outcomes from the disease.
However, the CDC says it has demographic data only a fraction of reported cases. Unlike its counterparts abroad in places like the United Kingdom and Europe, the agency must rely on details collected and reported "voluntarily" to the agency by local health departments.
As of Aug. 1, no deaths have been reported in the outbreak so far in the U.S. among the thousands who have been infected by monkeypox. A handful of deaths have been reported abroad, including in Africa, South America, and Europe.
Compared to its more lethal cousin smallpox, officials have said that cases often resolve after a few weeks without additional treatment. The variant linked to the current outbreak has been spreading in Nigeria since 2017, where around 3% of the people who contracted monkeypox died.
After an incubation period, which the CDC estimates is a little longer than a week on average, between exposure to an infected person and the first noticeable signs of the infection, patients generally must endure painful lesions as well as other symptoms like fever and swollen lymph nodes until their rashes scab over and heal. Like other poxviruses, monkeypox can leave scars.
However, authorities have been careful not to downplay the danger monkeypox's complications might pose beyond its physical pain.
For example, in the United Kingdom, authorities reported that some hospitalized patients faced "severe swelling" that might strangle circulation to the penis. In Spain, some patients were hospitalized due to bacterial infections of their sores.
The CDC says that the patients who are at "especially increased risk" for severe monkeypox disease include:
The agency also says that people living with HIV who have caught monkeypox during the current outbreak are not getting a more severe disease, as long as they are on treatment that is suppressing HIV.
Monkeypox cases to date in the U.S. have been diagnosed using CDC's lab test, which can tell whether someone is infected by an orthopoxvirus the family of bugs that includes both monkeypox and others like smallpox.
Those tests rely on doctors "vigorously" swabbing suspected lesions for samples that can be sent off to their state's public health labs that have launched the agency's test, as well as a growing number of commercial laboratories.
Some labs have also raced to develop their own tests for suspected monkeypox cases, including via saliva or blood samples, though the Food and Drug Administration currently warns these methods "may lead to false test results."
"We are actively doing studies to evaluate what other kinds of tests could be available, whether they are saliva tests, throat swabs, blood tests, but right now, we don't have the data to recommend using tests of those kinds," CDC Director Dr. Rochelle Walensky told reporters on July 15.
The Biden administration has deployed two vaccines, originally stockpiled by the country to prepare for a potential smallpox emergency, known as Jynneos and ACAM2000.
Both rely on versions of less-deadly relatives of smallpox to immunize their recipients. But unlike ACAM2000, Bavarian Nordic's Jynneos vaccine which was approved by the FDA in 2019 to specifically combat monkeypox as well carries far fewer risks because it relies on a version of the virus modified to prevent it from replicating and reduce its severity.
Before the current outbreak, the U.S. had contracted Bavarian Nordic to manufacture "bulk vaccine" worth some 13 million doses of the company's Jynneos shots. The administration has now ordered some 7 million doses of that vaccine to be filled into vials and shipped to them from Bavarian Nordic through mid-2023.
For now, federal officials have acknowledged that demand for the Jynneos far outstrips supply for the shots. Doses are being rationed for vaccinated either known close contacts of cases or others "presumed" to be at risk of having come into contact with a case, like having multiple recent sexual partners in a jurisdiction facing an outbreak.
Some jurisdictions have announced plans to try and stretch their supply relying on only offering one dose for now of the two-shot vaccine, despite the FDA discouraging the move.
More than 736,000 additional doses were made available for states on July 29, after an FDA inspection cleared use of a tranche of vaccine that had already been filled into vials from Bavarian Nordic.
Further waves of vaccinations will need to wait for doses the Biden administration ordered filled into vials back in June, which the company says it expects will be delivered by the end of the year.
The company also says it has supplied "nearly 30 million doses" of vaccine in the past, which have now expired. A spokesperson for the Department of Health and Human Services said on August 2 in a statement that it was working with Bavarian Nordic to test those doses to see if they can be salvaged, but acknowledged it was "highly unlikely that these doses remain viable."
Children are not currently FDA approved to be vaccinated with Jynneos, although CDC officials disclosed earlier this year to a panel of its outside vaccine advisers that at least one pediatric patient had been offered a shot. Agency officials and local health systems have since confirmed other children who were close contacts of monkeypox cases have also been offered shots.
Spokespeople for the FDA and CDC have declined to confirm how many requests have been granted for the use of the vaccine in children.
A spokesperson for Bavarian Nordic declined to offer details about whether it planned to trial the vaccine in children, but did say it planned to collect data on CDC's use of the shots.
While people in the current outbreak are now being vaccinated with vaccines initially designed to combat smallpox, like ACAM200 or Jynneos, officials have cautioned that Americans who were vaccinated for smallpox decades ago are unlikely to be protected from a monkeypox infection.
Though the U.S. stopped routine mass vaccination against smallpox in 1972, the CDC still recommends that scientists who are at risk of exposure because they work with orthopoxviruses including monkeypox in the lab get revaccinated every three years.
In the current outbreak, the CDC says some cases had been vaccinated against smallpox "decades prior." And in the 2003 outbreak, CDC researchers did not find evidence that previous smallpox vaccination among those infected reduced the odds of patients facing severe disease or being hospitalized.
"We do expect that people who have received the vaccine, even as children, will have some remaining immunity. But that is something that we're very interested in looking at, closely monitoring during this outbreak, to really define exactly how long that protection lasts and how much benefit people who have received vaccination many decades prior may still receive," said the CDC's Brett Petersen said on June 30, in a webinar with clinicians.
While many monkeypox cases eventually resolve without medications, aside from pain relievers, the Biden administration has allowed doctors to request stockpiled coursesof several treatments that have been developed in the past for smallpox.
The most commonly requested of those drugs is the antiviral tecovirimator TPOXX, which was developed out of federal research launched in 2002 to head off a potential bioterrorism attack. The FDA approved tecovirimat in 2018 to treat smallpox cases. However, that approval was in large part actually based on studies in animals infected with monkeypox and rabbitpox, with the regulator deeming it "not feasible or ethical to conduct efficacy trials in humans" for smallpox.
Doctors looking to get courses of tecovirimat for their monkeypox patients must request them from the CDC under an "expanded access" protocol, which it recently worked with the FDA to streamline.
The agency says that use of the drug is being considered for people with severe disease, or who have an additional risk factor such as a compromised immune system or lesions in a part of the body that "might constitute a special hazard" like on the genitals.
While health officials expect the number of monkeypox cases to continue to climb through at least August, authorities say they still hope to control the current outbreak.
"There is community spread occurring. And while public health officials are working around the clock to contain the outbreak, it's important to say that I think we expect that these numbers will continue to increase," the CDC's Jennifer McQuiston told a webinar hosted by the American Medical Association on July 14.
However, with more than 13,000 cases in the outbreak around the world as of July 18, some experts are skeptical public health authorities will be able to stem the spread of the virus.
"I think at this point, we've failed to contain this. We're now at the cusp of this becoming an endemic virus, where this now becomes something that's persistent that we need to continue to deal with," former FDA Commissioner Scott Gottlieb told "Face the Nation" on July 17.
"This has spread more broadly in the community. I wouldn't be surprised if there's thousands of cases right now," Gottlieb added later.
CBS News reporter covering public health and the pandemic.
The vaccine rollout for monkeypox is expanding, meaning that more people can be eligible to receive a vaccine for monkeypox.
However, there are still eligibility limits as to who can get a vaccine. Heres what you need to know.
According to Centers for Disease Control and Prevention (CDC) guidelines published by the New Jersey Department of Health (NJDOH), New Jersey residents are eligible to receive monkeypox vaccinations, if they:
For now, it is up to state and local health departments to distribute the monkeypox vaccines to the public.
Currently, you can get monkeypox vaccines in New Jersey and other states by contacting your nearest health department, which will most likely be at the city or county level.
Gov. Phil Murphy recently announced two monkeypox vaccination sites in Bergen and Camden counties, in addition to three sites in Newark, Asbury Park and Jersey City.
Our journalism needs your support. Please subscribe today to NJ.com.
Katherine Rodriguez can be reached at krodriguez@njadvancemedia.com. Have a tip? Tell us at nj.com/tips.
As cases reach 10,000 in the Region, Member States hold Special Session of the PAHO Directing Council to discuss best use of limited global vaccine supplies.
Washington D.C. 5 August 2022 (PAHO) As monkeypox cases continue to rise in several countries of the Americas, Member States of the Pan American Health Organization (PAHO) today held a Special Session of the Directing Council to consider a Resolution to address the outbreak, including supporting equitable access to vaccines for at-risk populations in the region.
On 23 July 2022, the Director of the World Health Organization (WHO) declared the outbreak, which began in mid-May and has affected 89 countries across all six WHO regions, a Public Health Emergency of International Concern (PHEIC).
Over 10,000 monkeypox infections have been reported by 24 countries of the Americas since the start of the outbreak. This accounts for 38% of global cases.
The PHEIC declaration came with detailed recommendations for both countries and territories who havent detected any cases as well as for those who already have imported cases or transmission in their communities, said PAHO Director, Carissa Etienne.
We believe that when the recommended measures are appropriately implemented, we can stop transmission of the monkeypox virus.
These recommendations, which PAHO is working with Member States to implement, include communication and engagement with affected communities, early detection and surveillance, treatment and isolation of patients, and contact tracing.
However, post- or pre-exposure vaccination might need to complement the other measures, the Director added.
During the session, Dr. Etienne noted that there is currently only one third-generation vaccine for monkeypox, which is produced by just one manufacturer.
While supplies of this vaccine are extremely limited, PAHO has engaged in early negotiations with its manufacturer.
In light of this, the Resolution adopted requests PAHOs Director to facilitate a coordinated response and take steps to support Member States in obtaining access to this vaccine through the PAHO Revolving Fund. It also requests that countries of the Region of the Americas continue to recognize PAHO and its Revolving Fund as the strategic regional technical mechanism most suitable for providing equitable access to this vaccine and others.
The recommendations of PAHOs Technical Advisory Group on Vaccine Preventable Diseases, as well as those of the Emergency Committee of the International Health Regulations, convened by the World Health Organization (WHO), stipulate that countries should prioritize vaccines for specific groups, such as close contacts of a confirmed monkeypox case, in order to maximize impact considering the limited vaccine supply.
Monkeypox diseaseMonkeypox is a viral zoonotic disease caused by the monkeypox virus. Symptoms include fever, intense headache, swollen lymph nodes, muscle ache, and a rash that blisters and crusts. The rash tends to be concentrated on the face, palms of the hands and soles of the feet. The mouth, genitals, and eyes may also be affected.
The symptoms can be mild or severe, and generally last for several weeks during which time a person can be infectious to others. Most people recover within a few weeks without treatment.
Monkeypox disease is reported regularly in nine countries of Central and West Africa since it was first recognized in 1958 in the Democratic Republic of Congo. However, since mid-May 2022, an increasing number of monkeypox cases have been reported first in multiple countries in Europe and later in other regions, including the Americas.
As of 5 August 2022, 37,360 probable and laboratory-confirmed cases were reported to the WHO from 89 countries across all six WHO regions.
Note to journalists: With updated number of cases as of 7:30 pm EDT, August 5.
ANDERSON The Indiana Department of Health (IDOH) is now offering the monkeypox vaccine to those that have been exposed to the illness or are at high-risk for exposure or severe illness. Hoosiers that are eligible can receive the JYNNEOS vaccine, which contains a live virus that does not replicate efficiently in human cells and is administered in two subcutaneous doses 28 days apart, according to the Centers for Disease Control (CDC) website.
As of Tuesday, the CDC reported 58 confirmed cases in Indiana. IDOH is only distributing the vaccine for both Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP) because a minimal amount of doses have been allocated to the state, according to its website.
PEP vaccines must be administered within four days of exposure to prevent the onset of monkeypox, and those who receive it 4 to 14 days after exposure may reduce symptoms but may not prevent illness. IDOH will expand vaccine eligibility to high risk groups once more vaccines have been allocated.
IDOH is currently reporting cases on a statewide basis and not by county in order to protect the identity of those that have contracted the illness, Madison County Health Department administrator Stephanie Mellinger said. The county health department has been assisting with case investigations in several counties, as well as implementing a plan that includes communicating with hospitals and clinics to help those in the county that may have been exposed or contracted monkeypox.
The state health department has passed down guidelines, and weve been sharing them and discussing them with all of our healthcare partners, Mellinger said. We have been in contact this entire time and making sure that we all understand that if we need to refer someone to get tested somewhere, that we alert that agency ahead of time, so that there isnt any further contamination.
The vaccine doses that have been received by the county health department last week are not issued for use by the general public and are only offered to those at high risk for transmission from a known case, Mellinger said. The federal government is currently working on making more doses available.
I dont know how quickly those extra doses will come. I dont know what that will look like, Mellinger said. If we can contain the virus prior to needing a situation where its available to the general public or necessary, its my hope that we can get on top of it before it gets to that point.
Anyone can contract monkeypox regardless of sexual orientation and gender identity, but current trends show that many of those affected in the outbreak are men who have sex with other men, as well as those living with HIV, according to the CDC website. CEO and President of the Damien Center Alan Witchey thinks those groups are more affected by the virus because a predomanance of gay men who are living with HIV and compromised immune systems are more likely to contract the illness.
The Damien Center is currently offering vaccination for men that engage in sexual activity with other men and people living with HIV, but may expand to people that are using PrEP prevention strategies for HIV. And while monkeypox can be spread through sexual activity because of skin-to-skin contact, Witchey said it is important to differentiate that it is not a sexually transmitted disease.
People can give it to their kids, they can give it to their roommates, they can give it to their family members, Witchey said. At this time, if you think youve been exposed, you definitely want to be careful. If youre engaging in ongoing behaviors where youre having skin to skin contact with somebody, you probably want to consider getting vaccinated.
For those that are concerned about contracting monkeypox, Mellinger said the most important way to prevent the illness is to wash your hands. The main symptom of the disease is a rash that looks like pimples or blisters that can appear on the face and other parts of the body, including inside the mouth.
Be mindful of any sores that may look like that. If anyone has any sores that look like that, please go to a health care provider to be tested, Mellinger said. If you happen to see anyone or know anyone who has sores like that, wash your hands, avoid contact with those sores.
What we all know as the flu is actually a collection of influenza virus strains that mutate (change) over time. Protecting yourself from these potentially dangerous viruses is best done by getting the flu vaccine and practicing everyday prevention techniques, like proper hand washing and avoiding sick people.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services.Policy
We talked with infectious disease doctorSherif Mossad, MD, about the many strains of flu and how you can keep from getting sick this flu season.
What all flu strains have in common are the symptoms they cause, Dr. Mossad says. Fever. Headache. Cough. Those are the three cardinal manifestations of all flu viruses. Flu can cause stomach issues for some people, too, but stomach flu is really a misnomer.
There are three types of flu viruses that affect people. Theyre known as influenza viruses A, B and C. Influenza A and influenza B viruses are the heavy hitters. Theyre the ones that cause the most severe illness and lead to widespread outbreaks. Influenza C viruses cause mild illnesses in people. Theyre more similar to a common cold, Dr. Mossad says, and they arent detected by flu tests.
(Fun fact: There is an influenza D virus, but its mostly found in cattle and hasnt been known to affect people.)
When people talk about the flu, its really influenza A and B viruses. Theyre the viruses that are responsible for our annual flu season.
Influenza A viruses are the most common flu viruses. Theyre the cause of regular seasonal flu outbreaks, as well as global flu pandemics. Influenza A viruses can affect both people and animals.
The 1918 pandemic and the 2009 H1N1 pandemic (what some people call the swine flu), for example, were Influenza A virus outbreaks.
Dr. Mossad says influenza A virus outbreaks usually occur earlier in the flu season. In the Northern Hemisphere, influenza A is most likely to make its rounds from October to March.
Common strains of influenza A include the H1N1 and H3N2 varieties.
Influenza B viruses affect only people, not animals, and they dont spread to the point of pandemics. Influenza B viruses are more likely to make you sick later in the flu season, from about January to May in the Northern Hemisphere.
There are so many different strains of flu viruses that the World Health Organization (WHO) created an internationally accepted naming convention to help track them.
The name of each virus is made up of:
So, for example, the A/Sydney/05/97(H3N2) virus is an influenza A virus that originated in Sydney, is strain number five, was collected in 1997 and is an H3N2 subtype.
Long story short: There are boatloads of flu strains out there. And theyre constantly changing and creating new viruses.
Dr. Mossad explains there are two ways the flu virus mutates.
Antigenic drift refers to the small ways in which the flu virus mutates each year. Antigenic drift is the reason for annual flu epidemics. So, even if you had one strain of H3N2 last year, its now a little different, and you can get it again this year.
Antigenic shift is a tidal wave of flu virus mutation.
Antigenic shift is when viruses change so much that you wind up with a virus that humans have never been exposed to at all, Dr. Mossad says. Thats what happened in 2009 with the H1N1 swine flu virus. It was an entirely new virus to humans, so no one had built up any immunity to it at all.
Each year, the WHO and the U.S. Centers for Disease Control and Prevention (CDC) monitor trends to determine the strains of flu thatll be most common. And each year, the flu vaccine is created to protect you from what these experts expect will be the two most prevalent influenza A viruses and two most prevalent influenza B viruses for that flu season.
For the 2022 flu season, the U.S. Food and Drug Administration (FDA) determined that egg-based influenza vaccines (the most commonly used vaccine method) would be formulated for these viruses:
Remember, the flu virus mutates. Fast. So getting a flu shot every year is the absolute best method to protect yourself from the strains that are likely to make their rounds this season.
In addition to getting your flu shot every fall, Dr. Mossad suggests these best practices to stay healthy this flu season:
More than half a million Victorians have received their free flu vaccine this flu season.
Health minister Mary-Anne Thomas on Thursday announced that more than 500,000 Victorians received a vaccine from more than 2,150 GPs and pharmacies that participated in the state governments $33 million free flu vaccine program between June 1 and July 10 this year.
The total number of people vaccinated for influenza has increased by 22.2 per cent from last year.
By removing as many barriers as possible, hundreds of thousands more Victorians rolled up their sleeves for a flu vaccination this year and helped protect their loved ones and our health system, Ms Thomas said.
Victorians have helped their families stay safe this winter by getting vaccinated for both the flu and COVID-19, getting tested if you have any symptoms, and staying home while unwell.
Even though rates of flu have declined from their peak, its still not too late to receive your flu vaccination.
Ms Thomas reiterated the importance of people, such as those in Wyndham, staying up to date with flu and COVID-19 vaccines.
Details: betterhealth.vic.gov.au/stay-well-this-winter.
industrydataanalytics market research published new research on Flu Vaccine covering the micro-level of analysis by competitors and key business segments (2022-2027). The global Flu Vaccine explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing.
The global Flu Vaccine Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 4.8% during the review period (2022 to 2027)
Some of the Major Key players profiled in the study are Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO and others.
Get a free sample copy of this report (20% discount)
https://www.industrydataanalytics.com/reports/flu-vaccine-market/inquiry?mode=126
The global Flu Vaccine Market research report delivers a comprehensive analysis of market size, market trends, and market growth prospects. This report also delivers extensive information on the technology expenditure for the forecast period, which gives a unique view of the global Flu Vaccine Market across numerous segments. The global Flu Vaccine market report also allows consumers recognize market prospects and challenges.
Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Flu Vaccine market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitutes, and the degree of competition prevailing in the market.
Global Flu Vaccine Market Split by Product Type and Applications:
Market Segmentation: By Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others
Market Segmentation: By Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Others
Key market aspects are illuminated in the report:
Executive Summary: It covers a summary of the most vital studies, the Global Flu Vaccine market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Flu Vaccine market, the years measured, and the study points.
Company Profile: Each Firm well-defined in this segment is screened based on a product, value, SWOT analysis, their ability and other significant features.
Production by region: This Global Flu Vaccine report offers data on imports and exports, sales, production and key companies in all studied regional markets
Market Dynamics: This report covers the drivers, trends and opportunities of the global Flu Vaccine Market. This section also includes Porters analysis of five forces.Access Full Summary @ https://www.industrydataanalytics.com/reports/flu-vaccine-market?mode=126
Highlighting points of Global Flu Vaccine Market Report:
Table of Contents
Global Flu Vaccine Market Research Report 2022 2027
Chapter 1 Flu Vaccine Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Flu Vaccine Market Forecast
Conclusion: The Report provides strong recommendations for new as well as established players for securing a position of strength in the global Flu Vaccine Market.
Additional paid Services:
About Us:
IndustryDataAnalytics is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resources, automobile, IT, technology and media, food and beverages, and consumer goods, among others.
Head of Sales: Mr. Hon Irfan Tamboli
+1 (704) 266-3234 | contact@industrydataanalytics.com
The numbers as at 29 July 2022
Getting the flu vaccine helps reduce your risk of getting really sick or having to go to hospital.
As expected, many are presenting at hospital with severe flu-related symptoms. Funded eligibility for the flu vaccine has been extended.
Flu vaccines are free for those people most likely to get very sick people who are over 65 years of age; Mori and Pacific people over 55 years of age; pregnant people; tamariki aged 3-12 years old, and those with underlying and other health conditions.
We encourage everyoneto get afluvaccination if they are not yet immunised.
We also remind peopleto stay home if they are unwell, regardless of their COVID-19 test result. Staying home when unwell is one of the most important public health measures to prevent transmission of all respiratory illnesses.
From1 July, flu vaccinations became free for all tamariki aged 3-12 years old, and for people with serious mental health conditions or addiction.To keep your child and whnau healthy this winter, its important they have a flu vaccination, and are also up to date with their other vaccinations, including COVID-19 andMMR.Tamariki aged under 9 may require two doses of the flu vaccination, 4 weeks apart, if they have not had it before.
Data may vary from week to week as flu records are updated
